Both in Biotechnology
CG Oncology vs Immunovant
Over the past year CGON returned +49.5% and IMVT returned +18.2%; their daily moves had a correlation of 0.38.
CGON +49.5% IMVT +18.2%Growth of $1, one year, split-adjusted
| Metric | CGON | IMVT |
|---|---|---|
| Price | $64.68 | $29.17 |
| Market cap | $5.73B | $6.03B |
| Today | +1.91% | −1.59% |
| 1 month | −5.4% | −13.3% |
| 6 months | −2.4% | +7.6% |
| Year to date | +55.8% | +14.8% |
| 1 year | +50.5% | +34.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | −239.2% | — |
| Net margin | −6832.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 920.6× | — |
| Net cash | $1.03B | $797.8M |
| Dividend yield | — | — |
| Volatility (60d) | 40.3% | 36.8% |
| Short % of float | 12.9% | 21.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).